HashemBeshirEl-SeragMDMPH

Gastroenterology • Houston, TX

Professor and Chairman, Department of Medicine at Baylor College of Medicine Chief, Gastroenterology & Hepatology

Join to view full profile

Dr. El-Serag is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. El-Serag's full profile

Already have an account?

Office
6620 Main St
Houston, TX 77030
Phone+1 713-798-2500

Fax+1 713-748-7359

Summary

Hashem B. El-Serag, MD, MPH
Margaret M. and Albert B. Alkek Chair of the Department of Medicine
Baylor College of Medicine Houston, Texas

Hashem B. El-Serag, MD, MPH, obtained his medical degree from Al-Arab Medical University in Libya, completed his internship and residency in internal medicine (1995) at Greenwich Hospital, Yale University, Connecticut, and completed a fellowship in clinical gastroenterology (1997) at the University of New Mexico, Albuquerque, New Mexico, where he also earned a master’s degree in public health (1998). In 1999, Dr. El-Serag joined the Michael E. DeBakey VA Medical Center and Baylor College of Medicine in Houston, where he become chief of the Section of Gastroenterology and Hepatology (2007-2016), leader of the clinical epidemiology and outcomes program at Houston Center for Quality of Care and Utilization Studies (2005-2013), leader of Cancer Prevention and Population Sciences at Dan L Duncan Cancer Center (2009-2015) and Director of NIH funded Texas Medical Center Digestive Disease Center (2013-to date). Effective January 1, 2017 he will be the new Chairman of the Department of Medicine, Baylor College of Medicine.

Dr. El-Serag’s research focuses on the clinical epidemiology and outcomes of several digestive disorders, including GERD, Barrett's esophagus, esophageal adenocarcinoma, hepatocellular carcinoma and hepatitis C. His seminal work on hepatocellular carcinoma, “Rising Incidence of Hepatocellular Carcinoma in the United States,” was published in 1999 in the New England Journal of Medicine and has been cited more than 3000 times. Dr. El-Serag has more than 400 published articles. Several of his studies were published in notable journals, such as the New England Journal of Medicine, Annals of Internal Medicine, Gastroenterology, Hepatology, and Gut. Dr. El-Serag has obtained more than 50 research grants including multiple continuous funding from the National Institutes of Health and Veteran Affairs, Cancer Preven

Hashem El-Serag - Wikipedia

El-Serag was born in 1966 in Libya to Palestinian parents from the Gaza Strip. He received his M.D. from Al-Arab Medical University in Benghazi, Libya. He then

Education & Training

University of New MexicoMPH, 1997 - 1998
University of New Mexico School of MedicineFellowship, Gastroenterology, 1995 - 1997
Greenwich Hospital/Yale UniversityResidency, Internal Medicine, 1993 - 1995
OtherClass of 1991
Garyounis University Faculty of MedicineClass of 1991
Al-Arab Medical UniversityNon-degree, 1983 - 1984

Certifications & Licensure

TX State Medical License 2000 - 2026
NM State Medical License 1995 - 2000
CT State Medical License 1994 - 1995

Awards, Honors, & Recognition

Bin Qurrah Award, National Arab American Medical Association NAAMA, 2016
Michael E. DeBakey Excellence in Research Award Baylor College of Medicine, 2016
“World Most Influential Scientific Minds, 2014” in the area of Clinical Medicine by Thompson Reuter 2014
American Clinical and Climatological Association (ACCA), elected member ACCA, 2013
Michael E. DeBakey Excellence in Research Award 2016
Bin Qurrah Award National Arab American Medical Association, 2016
Top Doctors of the Year 2014
"World Most Influential Scientific Minds, 2014" Thompson Reuter, 2014
Elected Member American Clinical and Climatological Association (ACCA), 2013
Elected Member Association American Physicians, 2013
Top Doctors:SE Texas Castle Connolly, 2013
Blue Faery Award for Excellence in Liver Cancer Research 2011
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Texas Super Doctors 2011, 2013, 2015
Charles Mortel Lecture International Cancer Society, 2010
Houston's Best Doctors 2009-2012, 2014-2015
Best Doctors in America® 2009
Elected Member American Society for Clinical Investigators (ASCI), 2008
Elected Member The American Society for Clinical Investigation, 2008
Master's Award in Clinical Research The American Gastroenterological Association, 2006
John M. Eisenberg Memorial Lectureship on Therapeutics Research 2003
Research Award The American Society for Gastrointestinal Endoscopy, 2003
Young Clinical Investigator Award Gastroenterology Research Group (GRG), 2002
Research Award The American Digestive Health Foundation, 2001
Research Award The American College of Gastroenterology, 2001, 2006
"Special Contribution Award" Department of Veterans Affairs, 1999
Research Mentor Award University of New Mexico, 1999
The "Medical University Award" 1985
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Functional Dyspepsia Treatment Trial Start of enrollment: 2006 Oct 01
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

2390 citations
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
Gastroenterology. 2012-05-01
59 citations
Higher serum testosterone is associated with increased risk of advanced hepatitis C–related liver disease in males†‡
Donna L. White, Shariar Tavakoli-Tabasi, Jill Kuzniarek, Rhia Pascua, David Ramsey
Hepatology. 2012-03-01
899 citations
Epidemiology of Hepatocellular Carcinoma.
Katherine A. McGlynn, Jessica L. Petrick, Hashem B. El-Serag
Hepatology. 2021-01-01

Journal Articles

Sex and Racial Disparity in Incidence of Esophageal Adenocarcinoma: Observations and Explanations
Thrift AP, El-Serag HB, Clin Gastroenterol Hepatol, 1/31/2015
Reply
Khan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, El-Serag HB, Kanwal F, Clin Gastroenterol Hepatol, 1/10/2015
Comparison of endoscopic ultrasound guided 22-gauge core needle with standard 25-gauge fine-needle aspiration for diagnosing solid pancreatic lesions
Berzosa M, Villa N, El-Serag HB, Sejpal DV, Patel KK, Endosc Ultrasound, 1/1/2015
Hepatology 2014: where are we going?
Pellicano R, El-Serag HB, Minerva Gastroenterol Dietol, 1/1/2014
Poor sleep quality and obstructive sleep apnea in patients with GERD and Barrett's esophagus
Vela MF, Kramer JR, Richardson PA, Dodge R, El-Serag, HB, Neurogastroenterol Motil, 1/9/2013
Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressant in functional dyspepsia, evaluating symptoms, psych...
Talley NJ, Locke GR 3rd, Herrick LM, Silvernail VM, Prather CM, Lacy BE, Dibaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR, Contemp Clin Trials, 1/10/2012
Report on a single topic Conference on "Chronic Viral Hepatitis-strategies to improve effectiveness of screening and treatment"
Ward JW, Lok AS, Thomas DL, El-Serag HB, Kim WR, Hepatology, 1/22/2011
Prevalence of colorectal polyps in pediatric colonoscopy
Thakkar K, Alsarraj A, Fong E, Holub JL, Gilger MA, El-Serag HB, Dig Dis Sci, 1/7/2011
Current Concepts: Hepatocellular Carcinoma
El-Serag HB, N Engl J Med, 1/1/2011
Hepatocellular carcinoma at the cutting edge of science and practice
Pellicano R, El-Serag HB, Rizzetto M, Minerva Med, 1/1/2010
Hepatocellular cancer care: Cost is important, but only one factor of disease burden
Kanwal F, El-Serag HB, J Hepatol, 1/1/2009
Hepatitis C infection: Dying with or from the infection?
El-Serag H, Kramer JR, J Hepatol, 1/1/2008
GI Epidemiology: databases for epidemiological studies
Davila JA, El-Serag HB, Aliment Pharmacol Ther, 1/15/2007
HuGE Reviews and Meta-analysis of Gene Association Studies
El-Serag H, Khoury MJ, Lewis JD, Gastroenterology, 1/1/2007
HBV Vaccination and Hepatocellular Carcinoma
El-Serag HB, McMahon, The Year in Vaccination, 1/1/2007
EGD in Children with Abdominal Pain: A Systematic Review
Thakkar K, Gilger M, Schulman R, El-Serag HB, Am J Gastroenterol, 1/1/2007
Screening HIV-Infected Individuals for Anal Cancer Precursor Lesions: A Systematic Review
Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag HB, Clin Infect Dis, 1/1/2006
The association of body mass index with Barrett's oesophagus: author's reply
El-Serag H, Aliment Pharmacol Ther, 1/1/2006
Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers
El-Serag HB, Satia JA, Rabeneck L, Gut, 1/1/2005
Increased use of low anterior resection for veterans with rectal cancer
Abraham NS, Davila J, Burger D, Rabeneck L, El-Serag HB, Aliment Pharmacol Ther, 1/1/2005
The Association of Body Mass Index and Barrett's Esophagus
Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE, Aliment Pharmacol Ther, 1/1/2005
Childhood GERD is a risk factor for GERD in adults
El-Serag HB, Gilger M, Carter G, Genta RM, Rabeneck L, Am J Gastroenterol, 1/1/2004
The effect of surgical volume on long-term outcomes among veterans with colorectal cancer
Rabeneck L, Davila J, El-Serag HB, Am J Gastroenterol, 1/1/2004
Outcomes of surgical fundoplication in children with gastroesophageal reflux
Gilger MA, Yeh C, Chiang J, Dietrich C, Brandt ML, El-Serag HB, Clin Gastro Hepatol, 1/1/2004
Systematic review: natural history of irritable bowel syndrome
El-Serag HB, Pilgrim P, Schoenfeld P, Aliment Pharmacol Ther, 1/1/2004
Join now to see all

Books/Book Chapters

Clinical Dilemmas in Primary Liver Cancer
Chapter: Are Patterns and Prevalence Changing?
El-Serag, HBEditors: R. Williams and S. Taylor-Robinson.Wiley-Blackwell, A John Wiley & Sons, Ltd.2012
Hepatocellular Carcinoma-Current Clinical Oncology
Chapter: Epidemiology of Hepatocellular Carcinoma.
White DL, Firozi A, El-Serag, HBEditors: B.I. Carr.Humana Press, a part of Springer Science+Business Media, LLC2010
Epidemiology and Molecular Epidemiology in GI Oncology-A Critical Multidisciplinary Approach
Chapter: Epidemiology of Hepatocellular Carcinoma.
El-Serag HB, White D, Nurgalieva ZEditors: Jankowski J.2008
GI Epidemiology
Chapter: Database Research.
Davila J, El-Serag HBEditors: Talley NJ, Locke III R, Saito Y.2006
Therapy of Digestive Disorders
Chapter: Primary tumors of the liver.
El-Serag HBEditors: MM Wolfe.2006
Contemporary Diagnosis and Management of Upper GI Disorders
El-Serag HB, Graham DY2005
Join now to see all

Abstracts/Posters

Incidence and Predictors of Hepatocellular Carcinoma following Sustained Virological Response: A National Cohort Study.
El-Serag HB, Richardson P, Kanwal F, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
Costs per Diagnosed Liver Disease Stage among Individuals with Chronic Hepatitis C-Virus in the Veteran Health Administration.
Kramer JR, Richardson P, Liffmann D, El-Serag HB, Rein DB, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
Comparative Effectiveness of Screening of Hepatocellular Carcinoma in Veteran.
Mittal S, Chung R, Sada Y, Kanwal F, Temple S, May SB, Ying J, Davila JA, El-Serag HB, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
Demographic Predictors of Direct Acting Antiviral Receipt in Individuals with Hepatitic C Virus Infection.
Kanwal F, Kramer JR, Cao Y, Taylor T, Smith D, Asch S, El-Serag HB, American Association for the Study of Liver Disease's, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
Gastric Physiology Test Correlations in Functional Dyspepsia. AGA Research Forum
Saito YA, Almazar AE, Locke G, Camilleri M, Burton DD, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham B, El-Serag HB, Moayyedi P, Herric LM, Szarka LA,..., Digestive Disease Week, 1/1/2015
Review and Publications in the 20th Century.
El-Serag, HB, AGA Committee Sponsored Symposium, Digestive Disease Week, 1/1/2015
Cirrhosis and Liver Cancer: Out of mind but Not out of Sight.
El-Serag, HB, American Association for the Study of Liver Diseases (AASLD) Clinical Symposium, Digestive Disease Week, 1/1/2015
Tuberculosis and hepatitis B reactivation are rare after treatment with tumor necrosis factor antagonist therapy among patients with inflammatory bowel disease.
Hou, JK, Kramer, JR, Richardson, P, Sansgiry, S, El-Serag, HB, AGA Research Forum, Digestive Disease Week, 1/1/2015
Statins are underutilized in patients with nonalcoholic fatty liver disease and dyslipidemia.
Blais P, El-Serag HB, Kramer JR, Kanwal F, American Association for the Study of Liver Diseases (AASLD) Topic Forum, Digestive Disease Week, 1/1/2015
Cirrhosis is under recognized in patients subsequently diagnosed with HCC.
Kanwal, F, Walker, M, Sada, YH, Mittal, S, Duan, Z, El-Serag, HB, Davila, J, Digestive Disease Week Abstract, 1/1/2015
Metabolic syndrome and the risk of Barrett's Esophagus in white males.
Thrift AP, Hilal J, El-Serag HB, Digestive Disease Week-AGA Abstracts, 1/1/2015
Obesity, adipokines, inflammatory markers and risk of neoplastic progression in "BE: A cohort study.
Qureshi Z, Thrift AP, Kramer JR, Ramsey DJ, El-Serag, HB, Digestive Disease Week-AGA Abstracts, 1/1/2015
Statin use may decrease the risk of esophageal adenocarcinoma (EA): A nested case-control study of US veterans.
Nguyen T, Duan Z, Naik A, Kramer JR, El-Serag HB, Digestive Disease Week-AGA Abstracts, 1/1/2015
Changes in the incidence and prevalence of cirrhosis in the National Veterans Administration over a decade: 2002-2012.
Tansel A, Natarajan Y, Shukla R, Kramer JR, El-Serag HB, Walder AM, Kanwal F, Digestive Disease Week Abstract, 1/1/2015
The prevalence of Barrett's Esophagus in Asian counties: A systematic review and meta-analysis.
Shiota S, Singh S, Anshasi A, El-Serag HB, Digestive Disease Week Abstract, 1/1/2015
Autoimmune hepatitis and the incidence of hepatocellular carcinoma: A systematic review.
Tansel A, Parepally M, Katz LH, Shakhatreh MH, Kopylov U, Raza A, El-Serag HB, Kanwal F, Digestive Disease Week Abstract, 1/1/2015
Psychosocial interventions to achieve abstinence in patients with chronic liver disease and alcohol use disorders: A systematic review.
Khan A, Tansel A, White D, Blais P, Lindsay J, El-Serag HB, Kanwal F, Digestive Disease Week-AGA Abstracts, 1/1/2015
Primary prophylaxis with non-selective beta-blockers in patients with cirrhosis-A chasm between efficacy and effectiveness.
Shukla R, Kramer JR, Tansel A, Natarajan Y, Ying J, Walder AM, Advani S, El-Serag HB, Kanwal F, Digestive Disease Week Abstract, 1/1/2015
Treatment and outcomes of chronic hepatitis C (CHC) in the elderly.
El-Serag HB, Duan Z, Kramer JR, Kanwal F, Digestive Disease Week Abstract, 1/1/2015
HCV-related complications are increasing in women veterans: A national cohort study.
Kramer JR, Taylor TJ, Cao Y, El-Serag HB, Asch S, Smith DL, Kanwal F, Digestive Disease Week Abstract, 1/1/2015
Angiotensin converting enzyme inhibitors (ACE) are not associated with severity of fibrosis in patients with Hepatitis C virus (HCV).
Nguyen T, El-Serag HB, White D, Ramsey DJ, Kalin A. Kuzniarek J, Kanwal F, Digestive Disease Week Abstract, 1/1/2015
Is proton pump inhibitor use associated with delayed gastric emptying in functional dyspepsia subject?
Almazar AE, Saito YA, Locke G, Camilleri M, Burton DD, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham B, El-Serag HB, Moayyedi P, Herric LM, Szarka LA,..., Digestive Disease Week Abstract, 1/1/2015
Functional dyspepsia treatment trial (FDTT): Effect of antidepressants on mood response in functional dyspepsia.
Almazar AE, Saito YA, Herrick LM, Locke G, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Parther CM, Abraham B, El-Serag HB, Moayyedi P, Szarka LA, Hamilton FA, Tilkes KE..., Digestive Disease Week Abstract, 1/1/2015
Functional dyspepsia treatment trial (FDTT): Association of adequate relief response and psychological measures.
Herrick LM, Saito YA, Almazar AE, Locke G, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham B, El-Serag HB, Moayyedi P, Szarka LA, Hamilton FA, Tilkes KE..., Digestive Disease Week Abstract, 1/1/2015
Thanks but no thanks: Why was my paper rejected?
El-Serag, H, Omary, BM, Digestive Disease Week, 1/1/2014
Join now to see all

Lectures

Clinical Triad: Upper Gastrointestinal Tract
2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
"Writing and Speaking for Success"
Houston, TX - 1/20/2016
"Clinical Epidemiology, Lifestyle and Environmental Risk Factors"
Leesburg, VA - 1/3/2016
"Update Surveillance of HCC in USA"
Tokyo, Japan - 1/2/2016
"Epidemiology of Hepatocellular Carcinoma"
Karolinska Institute, Stockholm, Sweden - 1/28/2015
"A Critical Review of the Evidence Linking Diabetes and Obesity to the Liver Disease"
Vienna, Austria - 1/20/2015
"Obesity and Hepatocellular Carcinoma"
Lyon, France - 1/16/2015
"Functional Abdominal Pain"
VA Medical Center - 1/29/2014
"GERD and Barrett's Esophagus"
Hamad Hospital, 2014; First Al-Wakra Hospital, Doha, Qatar, 2014 - 1/27/2014
"Giving an Oral Presentation..Like a Pro"
Houston, TX - 1/24/2014
"Manuscript Skills Workshop"
Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX - 1/19/2014
"When Reflux Symptoms Persist Despite of PPI: What Should We Do"
Vienna, Austria - 1/17/2014
"Global Epidemiological Trends in Liver Cancer"
San Francisco, CA - 1/16/2014
"Changing Patterns in Epidemiology"
Paris, France - 1/13/2014
"Functional GI Disorders"
Kleberg Auditorium, Baylor College of Medicine - 1/13/2014
"Population-Based Study of Digestive Cancer-a Real World Data"
Kaohsiung, Taiwan - 1/4/2014
"Epidemiology and Impact of Hepatitis-Induced Liver Cancer"
Heidelberg, Germany - 1/3/2014
"Beverage Intake and the Risk of Advanced Fibrosis in HCV: Coffee, Tea, or Sodas?"
Chicago, IL - 1/1/2014
ILCA 2013 - International Liver Cancer Association Seventh Annual Conference
International Liver Cancer Association (ILCA), Washington, Dist Of Col - 9/13/2013
"Epidemiology and Outcomes of HCC in the US"
University of Buffalo, The State University of New York, Buffalo, NY - 1/25/2013
"Current Insights into the Management of Hepatic Encephalopathy"
Houston, TX - 1/25/2013
"Obesity and the Risk of Barrett's Esophagus"
Houston, TX - 1/25/2013
"Disease Burden due to Viral Hepatitis C: Can We Make a Difference?"
Philadelphia, PA - 1/22/2013
"Controversies in Screening for Hepatocellular Carcinoma"
Orange County Convention Center, Orlando, FL - 1/19/2013
"Hepatocellular Carcinoma Lecture"
Inova Fairfax Hospital, Washington, DC - 1/18/2013
Join now to see all

Other

Screening for Gastric Cancer.
El-Serag HB, Cancer Screening, World Health Organization (WHO) Monograph
1/1/2003
GERD
El-Serag HB, American Gastroenterology Association Monograph
1/1/2002
Hepatitis C update (audiotape)
El-Serag HB, Clinical Advances in Gastroenterology
1/1/2001

Press Mentions

Study Shows Synergistic Association Between Genetic and Behavioral Risks for Liver DiseaseOctober 3rd, 2022
Baylor Receives NCI Grant to Study Liver Cancer Risk and PreventionAugust 4th, 2022
How We Approach It: Treatment Options for Hepatocellular CarcinomaMay 1st, 2020
Join now to see all

Grant Support

Research Training In GasteroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
Program Leaders---Cancer PreventionNational Cancer Institute2010–2011
Epidemiology And Outcomes Of Digestive And Liver Diseases: A Mentoring ProgramNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Obesity, H Pylori And Risk Of Barrett'S EsophagusNational Cancer Institute2007–2011
Comparative Effectiveness Of Screening And Surveillance EndoscopyNational Cancer Institute2010
Surveillance For Hepatocellular Carcinoma Among Hcv-Infected VeteransNational Cancer Institute2007–2009
Gene Expression In Barrett'S EsophagusNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006